. This proposal centers around the development of a commercial kit for DNA sequencing applications. The kit will contain a hyperstable protein that has been characterized by the applicant and determined to eliminate the majority of sequencing artifacts by its inclusion in sequencing reactions. Phase I consists of a feasibility study to formulate the kit for cycle sequencing reactions, including optimization of components and protocols. Phase II will include testing of the kit on the most difficult templates, optimization for fully automated sequencing projects and optimization aimed at diagnostic DNA sequencing applications.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM055485-01
Application #
2024045
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (12))
Project Start
1997-03-15
Project End
1997-09-14
Budget Start
1997-03-15
Budget End
1997-09-14
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Fidelity Systems, Inc.
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20879
Slesarev, A I; Belova, G I; Lake, J A et al. (2001) Topoisomerase V from Methanopyrus kandleri. Methods Enzymol 334:179-92